MRZM Stock Price, Chart, Stats & News

Marizyme, Inc.
Save
Marizyme, Inc. (MRZM) does not currently pay a dividend.
39,538
Market cap
–
Current P/E
–
Forward P/E
MRZM chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Marizyme, Inc. is a life sciences company primarily engaged in bringing innovative medical technologies from development to market. Its offerings include DuraGraft, a unique single-application treatment administered during vascular and bypass surgeries, engineered to maintain the function and structure of the endothelium, along with other critical characteristics. The company is also progressing with various therapeutic products utilizing its Krillase protease-based platform.
Similar securities
Based on sector and market capitalization
Report issue





